Masayasu Okada

1.0k total citations
45 papers, 593 citations indexed

About

Masayasu Okada is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Masayasu Okada has authored 45 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 16 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Masayasu Okada's work include Glioma Diagnosis and Treatment (19 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Brain Metastases and Treatment (5 papers). Masayasu Okada is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Brain Metastases and Treatment (5 papers). Masayasu Okada collaborates with scholars based in Japan, United States and Russia. Masayasu Okada's co-authors include Yukihiko Fujii, Yoshihiro Tsukamoto, Manabu Natsumeda, Akiyoshi Kakita, Jun Watanabe, Makoto Oishi, Michihiro Igarashi, Daiki Kobayashi, Yuichiro Yoneoka and Naoto Watanabe and has published in prestigious journals such as Nature Communications, European Journal of Cancer and American Journal of Neuroradiology.

In The Last Decade

Masayasu Okada

41 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayasu Okada Japan 13 204 183 114 95 92 45 593
Marie‐Odile Joly France 11 237 1.2× 206 1.1× 118 1.0× 60 0.6× 129 1.4× 17 608
Junya Fukai Japan 12 147 0.7× 165 0.9× 78 0.7× 104 1.1× 71 0.8× 28 452
Jordan Jones Australia 14 152 0.7× 452 2.5× 77 0.7× 81 0.9× 149 1.6× 31 923
David L. Schonberg United States 10 187 0.9× 385 2.1× 104 0.9× 116 1.2× 196 2.1× 13 828
Vivian Tseveleki Greece 14 75 0.4× 339 1.9× 105 0.9× 136 1.4× 114 1.2× 19 855
Pierre‐Olivier Guichet France 14 150 0.7× 370 2.0× 75 0.7× 39 0.4× 163 1.8× 23 658
Lunshan Xu China 18 93 0.5× 357 2.0× 63 0.6× 76 0.8× 173 1.9× 33 682
Irune Ruiz Spain 13 151 0.7× 348 1.9× 62 0.5× 45 0.5× 207 2.3× 25 672
Susanne Kleber Germany 13 143 0.7× 610 3.3× 137 1.2× 137 1.4× 152 1.7× 15 1.1k
Efstathios Boviatsis Greece 17 216 1.1× 331 1.8× 52 0.5× 56 0.6× 201 2.2× 31 786

Countries citing papers authored by Masayasu Okada

Since Specialization
Citations

This map shows the geographic impact of Masayasu Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayasu Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayasu Okada more than expected).

Fields of papers citing papers by Masayasu Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayasu Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayasu Okada. The network helps show where Masayasu Okada may publish in the future.

Co-authorship network of co-authors of Masayasu Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Masayasu Okada. A scholar is included among the top collaborators of Masayasu Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayasu Okada. Masayasu Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natsumeda, Manabu, Akihide Koyama, Jun Watanabe, et al.. (2025). Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid. Pediatric Blood & Cancer. 72(4). e31535–e31535. 1 indexed citations
3.
Natsumeda, Manabu, Norikazu Hara, Akihide Koyama, et al.. (2024). Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis. Acta Neuropathologica Communications. 12(1). 14–14. 1 indexed citations
4.
Natsumeda, Manabu, Yoshihiro Mouri, Jun Watanabe, et al.. (2024). Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature. Brain Tumor Pathology. 41(2). 85–91. 3 indexed citations
5.
Magdeldin, Sameh, Masayasu Okada, Yoshihiro Tsukamoto, et al.. (2024). Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations. Journal of Neuro-Oncology. 166(1). 27–38. 1 indexed citations
6.
Natsumeda, Manabu, Akihide Koyama, Jun Watanabe, et al.. (2024). Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors. Journal of Neuro-Oncology. 166(2). 273–282. 3 indexed citations
7.
Sato, Taku, et al.. (2023). A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease. NMC Case Report Journal. 10(0). 169–175. 3 indexed citations
9.
Kondo, Naoki, et al.. (2023). Rheumatoid Arthritis and Reactive Oxygen Species: A Review. Current Issues in Molecular Biology. 45(4). 3000–3015. 18 indexed citations
10.
Natsumeda, Manabu, Kamon Shirakawa, Masayasu Okada, et al.. (2023). Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas. Thrombosis Research. 223. 36–43. 10 indexed citations
11.
12.
Natsumeda, Manabu, Michael Chang, Yoshihiro Tsukamoto, et al.. (2021). Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features. Brain Tumor Pathology. 38(3). 228–233. 9 indexed citations
13.
Abe, Hideaki, Manabu Natsumeda, Masayasu Okada, et al.. (2020). MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Frontiers in Oncology. 9. 1568–1568. 30 indexed citations
14.
Igarashi, Michihiro, et al.. (2020). Phosphoproteomic and bioinformatic methods for analyzing signaling in vertebrate axon growth and regeneration. Journal of Neuroscience Methods. 339. 108723–108723. 6 indexed citations
15.
Kondo, Naoki, et al.. (2020). The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3. Journal of Orthopaedic Surgery and Research. 15(1). 87–87. 29 indexed citations
16.
Okada, Masayasu, Atsuko Honda, Yasuyuki Ito, et al.. (2019). Phosphorylation sites of microtubule-associated protein 1B (MAP 1B) are involved in axon growth and regeneration. Molecular Brain. 12(1). 93–93. 24 indexed citations
17.
Natsumeda, Manabu, Hironaka Igarashi, Hideaki Abe, et al.. (2017). Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy. Neurosurgical Review. 41(2). 641–647. 20 indexed citations
18.
Yoneoka, Yuichiro, Junichi Yoshimura, Masakazu Sano, et al.. (2017). Third Ventricle Germ Cell Tumor Originating from the Infundibulum with Rapidly Expansive Enlargement. Pediatric Neurosurgery. 53(1). 49–54. 3 indexed citations
19.
Yoneoka, Yuichiro, et al.. (2014). Is Regression of Intracranial Germinoma Spontaneous or Diagnostic Radiation-Induced? A Case Report. Journal of Neurology Research. 4(1). 41–48. 1 indexed citations
20.
Yoneoka, Yuichiro, Naoto Watanabe, Masayasu Okada, & Yukihiko Fujii. (2013). Observation of the neurohypophysis, pituitary stalk, and adenohypophysis during endoscopic pituitary surgery: Demonstrative findings as clues to pituitary-conserving surgery. Acta Neurochirurgica. 155(6). 1049–1055. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026